Paper Review Records
全部论文审稿周期
10 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
35
天
Persistent low-level real human chorionic gonadotropin after gestational trophoblastic disease: Natural history and predictors of subsequent gestational trophoblastic neoplasia
作者
Raphael Alevato; Antônio Braga; Gabriela Paiva; Edward Araujo Júnior; Sue Yazaki Sun; Luana Giongo Pedrotti; Marina Bessel; Solange Artimos de Oliveira; Joffre Amim-Junior; Jorge Rezende-Filho; Ross Berkowitz; Neil Horowitz展开收起
作者单位
School of Medicine, Fluminense Federal University, Niterói, RJ 24070-090, Brazil; Department of Gynecology and Obstetrics, School of Medicine, Maternity School, Federal University of Rio de Janeiro, Rio de Janeiro, RJ 22240-003, Brazil; Department of General and Specialized Surgery, School of Medicine and Surgery, Federal University of the State of Rio de Janeiro, Rio de Janeiro, RJ 20270-004, Brazil; University of Vassouras, Vassouras, RJ 27700-000, Brazil; Department of Obstetrics, Paulista School of Medicine, Federal University of São Paulo (EPM-UNIFESP), São Paulo 04023-062, SP, Brazil; Hospital Moinhos de Vento, Porto Alegre, RS, Brazil; New England Trophoblastic Disease Center, Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA展开收起
37
天
Dynamics of HER2 status in recurrent cervical cancer: Highlighting the clinical value of reassessment
作者
Jun-Hyeong Seo; Yurimi Lee; Seongyun Lim; Young Eun Chung; Yoo-Young Lee; Chel-Hun Choi; Hyun-Soo Kim; Jeong-Won Lee展开收起
作者单位
Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea; Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea; Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea展开收起
72
天
A phase II study of androgen receptor inhibition by darolutamide in combination with leuprolide acetate and exemestane in recurrent adult-type ovarian granulosa cell tumor
作者
Elizabeth E. Hopp; Danielle Enserro; Susana Campos; Viola Chitiyo; Gloria Huang; Heather Lankes; Erin K. Crane; Anna Hoekstra; Jean Siedel; Debra L. Richardson; Carol Aghajanian; Janet S. Rader; Allan Covens展开收起
作者单位
Medical College of Wisconsin Cancer Center, Department of Obstetrics and Gynecology, 8701 W Watertown Plank Rd Milwaukee, WI 53226, USA; NRG Oncology, CTDD Biostatistics & Bioinformatics; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA; Dana Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA; Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA; Yale Cancer Center, 35 Park St, New Haven, CT 06519, USA; Division of Gynecologic Oncology, Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA; Levine Cancer Atrium Health Wake Forest Baptist, 1021 Morehead Medical Drive Charlotte, NC 28204, USA; CRC West Michigan Cancer Center, 200 North Park St, Kalamazoo, MI 49007, USA; University of Michigan, 1500 E Medical Center Dr, Ann Arbor, MI 48109, USA; University of Oklahoma, 800 NE 10th Street, Oklahoma City, OK 73104, USA; University of Toronto, Sunnybrook Health Centre, Odette Cancer Centre, 2075 Bayview Ave, Toronto, ON, M4N 3M5, Canada展开收起
72
天
Quality of life outcomes after sentinel lymph node biopsy in patients with early-stage cervical cancer: Results from the prospective multicentre SENTIX study
作者
Roman Kocian; Christhardt Koehler; Giampaolo Di Martino; Jaroslav Klat; Luc van Lonkhuijzen; Jiri Jarkovsky; Michal Zikan; Ignacio Zapardiel; Octavio Arencibia Sanchez; Blanca Gil-Ibanez; Francesco Raspagliesi; Jiri Presl; Lubos Minar; Radim Marek; Peter Kascak; Pavel Havelka; Martin Michal; Toon Van Gorp; Kristyna Nemejcova; Pavel Dundr; Sambor Sawicki; Martina Borcinová; David Cibula展开收起
作者单位
Gynecologic Oncology Center, Department of Gynecology, Obstetrics and Neonatology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic; Department of Obstetrics and Gynecology, Albertinen Hospital Hamburg, Germany; Department of Obstetrics and Gynecology, University Hospital Ostrava, Ostrava, Poruba, Czech Republic; Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic; Gynecologic Oncology Unit, La Paz University Hospital, Madrid, Spain; Department of Gynecologic Oncology, Amsterdam University Medical Center, Center for Gynecological Oncology Amsterdam, Amsterdam, Netherlands; Department of Obstetrics and Gynecology, Bulovka University Hospital, First Faculty of Medicine, Charles University, Prague, Czech Republic; Department of Gynecologic Oncology, University Hospital of the Canary Islands, Las Palmas de Gran Canaria, Spain; Unit of Gynecological Oncology, Institute Clinic of Gynecology, Obstetrics and Neonatology (ICGON), Hospital Clinic of Barcelona, Barcelona, Spain; Department of Gynecological Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Italy; Department of Gynecology and Obstetrics, University Hospital Pilsen, Charles University, Faculty of Medicine in Pilsen, Pilsen, Czech Republic; Department of Gynecology and Obstetrics, Faculty of Medicine, Masaryk University, University Hospital Brno, Brno, Czech Republic; Department of Obstetrics and Gynecology, Faculty of Medicine and Dentistry, Palacky University, University Hospital Olomouc, Olomouc, Czech Republic; Department of Gynecology and Obstetrics, Slovak Medical University and University Hospital, Bratislava, Slovak Republic; Department of Obstetrics and Gynecology, KNTB a.s, Zlin, Czech Republic; Department of Obstetrics and Gynecology, Hospital Ceske Budejovice, JSC, Ceske Budejovice, Czech Republic; Department of Gynaecological Oncology, University Hospital Leuven, Leuven Cancer Institute, Leuven, Belgium; Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic; Gynecologic Oncology Surgical Division, Humanitas San Pio X, Milan 20159, Italy; Gynecology Unit, IRCCS Fondazione San Gerardo dei Tintori, 20900 Monza, Italy; Department of Obstetrics, Gynaecology and Neonatology, Medical University of Gdansk, Poland展开收起
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天